News

What's New!

CO2 Solution's Collaborator, Codexis, Inc., Awarded ARPA-E Grant for Carbon Capture Clean Air Technology

 Codexis, Inc. will receive up to a $4.7 million grant from the U.S. Department of Energy

QUEBEC City, QC, May 5, 2010 – Codexis, Inc., a California-based company, has been selected to receive up to a $4.7 million from the U.S. Department of Energy, for the development of innovative technology, in collaboration with CO2 Solution, to remove carbon dioxide from coal-fired power plant emissions.

 

For additional details see Codexis press release below:


REDWOOD CITY, Calif., May 3, 2010  - Codexis, Inc. (US:CDXS) today announced that the company has been selected to receive up to a $4.7 million grant from the U.S. Department of Energy for development of innovative technology to remove carbon dioxide from coal-fired power plant emissions. This is the company's first grant under the ARPA-E Recovery Act program.

 
The grant supports development of biocatalysts for more efficient carbon capture from coal-fired power plants. Coal-fired power plants are major emitters of carbon dioxide, a significant greenhouse gas believed to contribute to global warming. The technology is based on customized carbonic anhydrase biocatalysts that have the potential to enable cost effective, energy efficient capture of carbon dioxide. Codexis is developing this technology in collaboration with CO2 Solution Inc. (CST) of Quebec City, Quebec, Canada.
 
According to the Department of Energy, the award was announced April 29 by Vice President Joseph Biden and Secretary of Energy Steven Chu as part of a $106 million award through the DOE's Advanced Research Projects Agency-Energy (ARPA-E) program. DOE made the award to projects that "could fundamentally change the way the country uses and produces energy" and "could produce advanced biofuels more efficiently from renewable electricity instead of sunlight; design completely new types of batteries to make electric vehicles more affordable; and remove the carbon pollution from coal-fired power plants in a more cost effective way."
 
Codexis, Inc. is a leading provider of optimized biocatalysts that make existing industrial processes faster, cleaner and more efficient than current methods and have the potential to make new industrial processes possible at commercial scale. Codexis has commercialized its biocatalysts in the pharmaceutical industry and is developing biocatalysts for use in producing advanced biofuels under a multi-year research and development collaboration. The company is also using its technology platform to pursue biocatalyst-enabled solutions in other bioindustrial markets, including carbon management, water treatment and chemicals.
 


-30- 

Contact:

Lyn Christenson

lyn.christenson@codexis.com

650-421-8144 or Saskia Sidenfaden

ssidenfaden@mww.com, 212-827-3771

SOURCE: Codexis, Inc.

Web Site: www.codexis.com

  

CO2 Solution Announces CDN$2 Million Equity Investment by Codexis and Collaboration in Carbon Capture

 

Joint Development Agreement to combine Codexis' industrially robust enzymes with CO2 Solution's carbon capture technology

 

Québec City, Québec, December 15, 2009 – CO2 Solution Inc. (“CO2 Solution”, TSX-V: CST) is pleased to announce that it has concluded a Joint Development Agreement (JDA) with Codexis, Inc. (“Codexis”) to accelerate the development and deployment of its enzymatic carbon capture technology.  Codexis has also completed a CDN$2 million equity investment in CO2 Solution and holds 16.59% of CO2 Solution's issued and outstanding common shares immediately following the subscription of common shares by Codexis.

 

Under the collaboration, CO2 Solution's proprietary enzymatic method for the efficient capture of carbon dioxide from coal-fired power plants and other large sources of emissions will be combined with Codexis' directed enzyme evolution technology. Coal-fired power plants are major emitters of carbon dioxide, a significant greenhouse gas (GHG) believed to contribute to global warming. CO2 Solution's technology uses the natural enzyme carbonic anhydrase to enhance CO2 absorption efficiency from power plant emissions, at lower cost than conventional technology. Codexis' technology will be used to improve this enzyme's ability to function in harsh industrial conditions. Carbonic anhydrase is found in humans and other mammals and is critical in the efficient management of CO2 during respiration.

 
(To see the integral press release please refer to the Press Releases Section)
 

 

CO2 Solution Announces Annual General Meeting

 

Quebec City, November 19, 2009 – CO2 Solution Inc. (“CO2 Solution” or the “Company”) is pleased to announce that its 2009 Annual General Meeting (AGM) will be held on Wednesday, November 25, 2009 at 7:00 pm EST, at the Pavillon La Laurentienne - Auditorium Jean-Paul Tardif - Room 1334, at Laval University in Québec City.

 

CO2 Solution will also be broadcasting the AGM live via a public Webcast. To listen to the AGM, please visit “www.cnw.ca/en/webcast” prior to the start of the event.

A site Siborg2